NN&I - July 2010
Renal Provider Profiles 50 Nephrology News & Issues July 2010Subscribe to our free eNewsletter at www.nephronline.com 1. Fresenius Medical Care North America2. DaVita Inc.920 Winter St. Waltham, MA 02451-1457 781.699.9000 www.fmcna.com www.ultracare-dialysis.com NYSE: FMS 1,793 clinics 132,381 patients As the nation's leading renal therapy provider, Fresenius Medical Care North America (FMCNA) is unified behind our UltraCare® mission to deliver outstanding outcomes for our patients in new and innovative ways. We remain confident that we are well positioned to meet all challenges, and we look forward to the opportunity to further improve quality outcomes under the new CMS reim-bursement model. Patient-centered care has been, and remains, a prime element of UltraCare. We believe this begins with education and awareness about Chronic Kidney Disease so patients and their family members are empowered with information to make the right decisions for their health. We conduct pro-grams nationwide, led by experts in kidney care, who review ALL options available for renal replacement therapy. In response to our UltraCare commitment to provide superior customer service, we continue to expand our home dialysis and nocturnal programs, supporting the preferenc-es of our patients who choose these options. Innovative Technology is another focus of UltraCare. Beyond the latest dialysis treatment technology, we are con-tinuing investment in our enterprise-wide information sys -tem called eCube®. Our AcumenTM nEHR, nephrology-specific Electronic Health Record, is the platform enabling the Acumen Physician Quality Reporting Initiative (PQRI), a participating CMS PQRI registry. 1551 Wewatta St. Denver, CO 80202 Phone: 303.405.2100 www.davita.com NYSE: DVA, Fortune 5001,529 clinics 120,400 patients DaVita Inc., a FORTUNE 500® company, is a leading provider of kidney care in the United States, providing dialysis ser -vices and education for patients with chronic kidney fail -ure and end stage renal disease. DaVita owns and operates approximately 1,560 outpatient dialysis facilities, serving approximately 120,400 patients. As part of DaVita's com-mitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous pro-grams dedicated to transforming communities and creating positive, sustainable change for children, families, and our environment. DaVita and its affiliated physicians collaborated to achieve outstanding clinical outcomes. In the key areas where better clinical performance has been associated with improved patient outcomes (dialysis access, nutrition, ade -quacy of dialysis, anemia management), we have had gratify- ing successes. As of April 2010: for dialysis better minimum recommended hemoglobin level. Additionally, DaVita's 2008 gross -ably to national averages. CEO: Kent Thiry CEO: Rice Powell RenalEconomics_13.indd 50 6/16/10 6:43:35 PM
You must have JavaScript enabled to view digital editions.
